Literature DB >> 27668535

Potential blood clotting factors and anticoagulants.

Ng Zhang Jin1, Subash C B Gopinath2.   

Abstract

Hemostasis initiates a wound healing process and stops bleeding of blood within a damaged tissue, an important process in human and animal systems. However, this process needs to revert temporarily during surgery and analyze the clotting mechanism. In the past decade, heparin has been used widely as an anticoagulant in surgery to prevent unwanted blood clotting as it is not expensive, not difficult to control, lack of suitable replacement as well as less harmful to the human. However, heparin has several disadvantages, which include thrombocytopenia and non-specific plasma binding. Moreover, using heparin it may lead dysfunction and platelet aggregation. In this overview, potential clotting factors and anticoagulants are reviewed and special focus was given to get more insights.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticoagulant; Aptamer; Factor IX; Factor IX-binding protein; Hemostasis; Heparin; Thrombin

Mesh:

Substances:

Year:  2016        PMID: 27668535     DOI: 10.1016/j.biopha.2016.09.057

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Citric acid-mediated green synthesis of selenium nanoparticles: antioxidant, antimicrobial, and anticoagulant potential applications.

Authors:  Aliyah S Alhawiti
Journal:  Biomass Convers Biorefin       Date:  2022-05-23       Impact factor: 4.050

Review 2.  Recent advances in the development of active hybrid molecules in the treatment of cardiovascular diseases.

Authors:  Harbinder Singh; Devendra K Agrawal
Journal:  Bioorg Med Chem       Date:  2022-03-11       Impact factor: 3.461

3.  Efficacy of Chitosan-Based Dressing for Control of Bleeding in Excisional Wounds.

Authors:  Anne-Heloise Stricker-Krongrad; Zahra Alikhassy; Nicolette Matsangos; Raul Sebastian; Guy Marti; Frank Lay; John W Harmon
Journal:  Eplasty       Date:  2018-03-10

4.  Anticoagulant Activities of Indobufen, an Antiplatelet Drug.

Authors:  Jia Liu; Dan Xu; Nian Xia; Kai Hou; Shijie Chen; Yu Wang; Yunman Li
Journal:  Molecules       Date:  2018-06-15       Impact factor: 4.411

5.  Venomous Landmines: Clinical Implications of Extreme Coagulotoxic Diversification and Differential Neutralization by Antivenom of Venoms within the Viperid Snake Genus Bitis.

Authors:  Nicholas J Youngman; Jordan Debono; James S Dobson; Christina N Zdenek; Richard J Harris; Bianca Op den Brouw; Francisco C P Coimbra; Arno Naude; Kristian Coster; Eric Sundman; Ralph Braun; Iwan Hendrikx; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2019-07-19       Impact factor: 4.546

Review 6.  Evaluation of Biological Activity of Natural Compounds: Current Trends and Methods.

Authors:  Carlos Barba-Ostria; Saskya E Carrera-Pacheco; Rebeca Gonzalez-Pastor; Jorge Heredia-Moya; Arianna Mayorga-Ramos; Cristina Rodríguez-Pólit; Johana Zúñiga-Miranda; Benjamin Arias-Almeida; Linda P Guamán
Journal:  Molecules       Date:  2022-07-13       Impact factor: 4.927

7.  CRISPR/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs.

Authors:  Jiahuan Chen; Beiying An; Biao Yu; Xiaohuan Peng; Hongming Yuan; Qiangbing Yang; Xue Chen; Tingting Yu; Lingyu Wang; Xinwei Zhang; He Wang; Xiaodong Zou; Daxin Pang; Hongsheng Ouyang; Xiaochun Tang
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.